← All trials
NCT04392362
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2018
- Primary completion
- Jul 21, 2020
- Completion date
- Aug 1, 2020
- First posted
- May 18, 2020
- Last posted
- May 18, 2020
- Enrollment
- 151
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of PretoriaLead sponsor
- University of PretoriaReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.